Live Breaking News & Updates on Corporate Affairs For Global Drug Development

Aditxt Therapeutics Names Sunny Uberoi as its first Chief Communications Officer
News provided by
Share this article
Share this article
MOUNTAIN VIEW, Calif., April 13, 2021 /PRNewswire/ Aditx Therapeutics, Inc. (Aditxt) (the Company ) (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced that Sunny Uberoi has joined the organization as its Chief Communications Officer. Uberoi joins Aditxt to raise the company s profile in advance of initiating its first-in-human clinical trials and support the rapid scaling of AditxtScore, a commercial technology platform designed to provide a personalized, comprehensive profile of the immune system. In this new role, Uberoi will be responsible for leading global corporate communications, investor relations, and government affairs.  ....

Amro Albanna , Bristol Myers Squibb , Prnewswire Aditx Therapeutics Inc , University Of Manchester , Corporate Affairs For Global Drug Development , Exchange Commission , Manchester Metropolitan University , Early Development , Aditxt The Company Nasdaq , Communications Officer , Sunny Uberoi , Chief Communications , Vice President , Corporate Affairs , Global Drug Development , Global Product Supply , Bristol Myers , Corporate Stakeholder Engagement , Global Communications , Consumer Health , Annual Report , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , பல்கலைக்கழகம் ஆஃப் மான்செஸ்டர் , பரிமாற்றம் தரகு , மான்செஸ்டர் பெருநகர பல்கலைக்கழகம் , ஆரம்ப வளர்ச்சி ,